Our Founders extensively patented in 2011 much of what is today modern telehealth. Our fully patented THAT, Timed Health Assistive Technology Platform is based on predictive data science which can form the basis for future artificial intelligence, which together enables the earliest form of healthcare therapeutics feasible which can help reduce the need for rationing costlier healthcare later.
Our goal is to help physicians forecast and enable providing medications that are 40% to 80% likely to be needed from one day to 4 months before actual need. When fully applied over time 30% of health and economic losses can be erased. Timed Health enhances patient empowerment, engagement and to improve health and economic outcomes beginning with low risk changes in asthma, diabetes, hypertension, infections, and sexual function in the first year. Thereafter growing into other acute and chronic health conditions, including cancer, dementia, heart, renal, and liver failure.
- 5 US patents issued and with more soon to be filed including two in the European, Canadian and India Patent Offices.
- Raised over $4M in previous funding now converted to common stock.
- Initial joint venture discussions have been held with Aon, Cerner, Cigna, Costco, Kaiser and Stanford University.
- Experienced team and Board of Directors with experience on both private and public company Boards.
HEALTHCARE DELAYS costly in time, money, stress and worsening health.
Highly patented Timed Health beats ignoring a NEW change in your health, or delaying your NEW healthcare. Or waking your doctor, or going to all night ERs and pharmacies for a minor change in your health before it worsens.Like a new infection, a new rising blood pressure or new rising blood glucose levels,
Highly patented, scalable, sustainable early priority date mass market telehealth, telemedications, forecasting and prescribing software platforms. Immediate patient implementation of forecasted stored timed new medications. Apps, online, on premises EMR and Employee Benefits to multiply user bandwidth, efficiency and ROI.
Diabetes and hypertension are only two of the many prevalent diseases that are too often ignored or treated too late. Mass demands are constantly increasing for more people to get better healthcare more often, efficiently, and affordably.
- These problems are often compounded by:
- Physician and consumer manpower shortages
- Low physician incomes and outcomes
- Healthcare inefficiency and insufficiency
- Costlier delayed healthcare
- Common cumulative disease progressive high-cost complicated outcomes
Timed Health’s (TH) platform is designed to help physicians time, forecast and provide determined prefilled new medications and healthcare supported by patented predictive data science. These options enable patients to have medications and healthcare in advance of their potential new medical, trial or gap-bridging medication needs.
Based on patented Predictive Data Science, TH is a comprehensive outpatient telehealthcare and telemedication software solution that is perfectly suited to assist doctors and patients with low-risk health issues to have easy, often immediate access to the medications they need quickly. Timed Health's solution is ideally e-prescribe and initiated prior to discharge from an online, office or clinic visit, ED or hospital to help avoid safely avoidable expensive admissions and readmissions - saving both the patient and the healthcare system health, time and money.
Recurring Revenue Model
Our products are software in the form of predictive data science, prescribing and electronic medical records software. Our business model makes money through technology sales to client hospitals, integrated delivery networks, employers, governments, insurers, physicians, patients, electronic medical records,and direct to consumers revenue streams.
Employers and Insurers
A pre-tax health benefit model is to become qualified within Series A.
Patented Software Assistive Electronic Medical Records.
Diabetes and Hypertension have a Total Addressable Market (TAM) of over $180 Bn in the US, afflicting approximately 50 million people, with a Serviceable Addressable Market (SAM) of 6 to 10 million people spending $15 to $30 Bn on ambulatory healthcare and medications.
US medication market sales in 2018 for antidiabetics was $78.7 billion, antibiotics and vaccines $40.6 billion, antihypertensive medications were $29.9 billion. Humira as an immunotherapy single drug example, alone in 2019 had $21.9 billion revenue, the largest for a single drug.
Timed Health does not employ physicians or retain as consultants physicians who are using Timed Health in their practice .
Standard Health Insurances and Health Savings Accounts (HSA) covers most healthcare and many telehealthcare physician fees. Physician practices wishing to move in the direct-pay direction price-tiered in part or in whole which can generate supplemental physician revenue.
Timed Health Early Bird Practices are those choosing to transform in-part to increasingly apply Timed Health Technology to more and more patients.
Or physicians may elect to transform their practices to high-end premium Timed Health Signature Practices which transforms their practice into being 100% focused on fully applied Timed Health technologies. Timed Health Signature Physician Practices reduce their census to care for fewer patients paying greater fees for greater access to their physicians. Patient Memberships supplement insurance reimbursement for physicians.
Timed Health Signature Physician Practices may charge patients $1,200 to $1,800 annually which passes through to Timed Health $300 to $450 per patient annually. Our Early Bird Practices charges are tiered in tenth percentiles, ranging from 10% to 50% of the Signature Level charges ranging from $0 to $900 annually for assistive technology fees for expedited services after-hours.
Direct to Consumer Patients and Physicians
Direct to consumer Timed Health Memberships begin at $0.25 per member per month.
Timed Health’s direct to consumer co-pay fees are based on physician time expenditure, urgency, complexity and connectivity to pre-authorize or authorize implementation of pre-filled new medications.
Fees may be charged to payers on a Direct-Pay, Health Savings Account, or certain pre-qualified Employer or Third-Party Payer co-pay basis. User fees are based on frequency and intensity of use, greater use lowers fees per determination and per implementation based on patient complexity and membership level.
Timed Health Co-Founder Angel Investor. Physician and Surgeon University of Maryland. Medical and Surgical Practice 3 Decades. Georgetown University BS. MD. George Washington University Surgery Board Certification. Lieutenant Colonel Retired Maryland Defense Force, 10th Medical Regiment, Medical Support for the National Guard. Current Maryland Health Care Commissioner.
Co-Founder Angel Investor. US Naval Officer. Prior Jet Aviator. Systems Engineer Annapolis US Naval Academy BS, Cornell MS. Executive at Allegheny Technologies.
Timed Health Co-Founder. Prior Executive Amazon OHL Bluestem. Prior CEO Cued Inc. Owner 1Click Logistics NV.
Healthcare BSN Toledo University. MBA Pepperdine. Prior Integrated Delivery Networks. Early-Stage Healthcare Companies Investor.
Prior Cued Inc.
Prior Cued Inc.
Advisors and Investors
Non-Executive Board Members
Prior Healthcare Strategy Lead KPMG. Columbia University Faculty.
Drucker and Scaccetti Tax Warriors. BOD Public Companies.
Finance, Prior Wall Street Fortune 500 Industry CFO, Partner CBIZ and BDO.
Consultancy Advisory Board
Jerry Friedman PhD
Stanford Department of Statistics. Machine Learning Pioneers.
Machine Learning Scientist.
Engineer Electromechanical integration.
University of Cambridge, UK. Senior Lecturer, Natural Language Processing.
Stanford Department of Medicine. Head of Health Product, Strategy & Operations, Google Search.
Prior VP Hewlett Packard Enterprises and Block Chain.
Cognitive Computing Consortium, AI Pioneer.
VC LLC Venture Capital and Intellectual Property.
VC LLC. Matt O’Connor, Partner. US Naval Officer. Prior Jet Aviator. Systems Engineer Annapolis US Naval Academy BS, Cornell MS. Executive at Allegheny Technologies. The Professionals VC LLC is comprised of Investors and Professional Service Providers: Controllers UCI MBA. Technology. IP. MD. Board Certifications Stanford. University of Pennsylvania. University of California. Harvard. Mayo Clinic Rochester. University of the Sciences PharmD. Consultants Healthcare Businesses.
Engineer Autonomous Vehicles, Tesla. GM.
Finance, prior CFO EHE Health, Aris Global, multiple healthcare successful exits.
Use of Proceeds
If the offering's maximum amount of $973,467 is raised:
|Use||Value||% of Proceeds|
|Compensation for managers||$60,000||6.2%|
|Legal and Government Fees||$100,000||10.3%|
|Marketing and Sales||$200,000||20.5%|
|Administration Fees, Hardware, Software||$65,767||6.8%|
This is an offering of Class B Common Stock, under registration exemption 4(a)(6), in Timed Health Corporation. This offering must raise at least $10,000 by May 1, 2021 at 12:59am ET. If this offering doesn’t reach its target, then your money will be refunded. Timed Health Corporation may issue additional securities to raise up to $973,467, the offering’s maximum.
If the offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:
These financial statements have been reviewed by an independent Certified Public Accountant.
The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemption 4(a)(6) of the Securities Act of 1933.
We’re also required to share links to each of the SEC filings related to this offering with investors.
Understand the Risks
Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.
Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.
The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
- Jul 29, 2022
- Jun 2, 2021
- May 1, 2021Primary offering finalized, sellingsharesSold $1 for a total of $42,933shares at
- Apr 23, 2021Timed Health: The Ambulatory Outpatient...
Timed Health: The Ambulatory Outpatient Medication Market Is Rapidly Growing. Timed Health is creating a new mass market for optimizing and “undelaying” new to the patient medications and new to the patient healthcare. Timed Health has a propriety highly patented opportunity and early priority position to lead this new mass market opportunity based in novel predictive analytics and medication distribution.Read more.
- Apr 23, 2021Billionaire Healthcare Investor Khosla agrees...
Billionaire Healthcare Investor Khosla agrees with the Timed Health 2008 envisioned initially planned future for healthcare with our proprietary 2011 priority date patented technologies as a 5-fold physician manpower and enhanced outcome multiplier.
https://www.youtube.com/watch?v=tBcMxiTF2pMPlease view this brief YouTube Video, Khosla has done several on this topic on YouTube.
- Apr 20, 2021Optum Launches Telehealthcare Nationwide Timed...
Optum Launches Telehealthcare Nationwide Timed Health 5 issued patents cover telehealthcare with priority date 2011Purchase Timed Health on Netcapital Series A1 $1 price per share Pre-Money Valuation $11 M Post-Money up to $12 M
- Apr 20, 2021Timed Health website updated "Undelaying...
Timed Health website updated “Undelaying Healthcare”$1 price per share Pre-Money Valuation $11 M Post-Money up to $12 M
- Apr 19, 2021Daniel Sohn New Timed Health Technology...
Daniel Sohn New Timed Health Technology Leader Timed Heath Mathematician Predictive Data Scientist Daniel Sohn brings 10 years experience. UCSD Mathematics BS and Economics BA https://www.linkedin.com/in/daniel-sohn-0ba181210/Purchase Timed Health on Netcapital Series A1 $1 price per share Pre-Money Valuation $11 M Post-Money up to $12 M
- Apr 15, 2021Microsoft acquired healthcare AI provider...
Microsoft acquired healthcare AI provider Nuance for $19.7B — its second-largest acquisition ever after its $26.2B purchase of LinkedIn. Nuance’s conversational AI solutions are already installed in 90% of US hospitals.
Timed Health is an early priority date patented player in the healthcare industry undergoing systematic changes, accelerated by the Covid-19 pandemic. Big tech companies Facebook, Amazon, Microsoft, Google, and Apple are using this opportunity to push ahead with their healthcare ambitions.
https://www.cbinsights.com/research/report/famga-big-tech-healthcare/?utm_source=CB+Insights+Newsletter&utm_campaign=49f4ddda6d-newsletter_general_Thurs_20210415&utm_medium=email&utm_term=0_9dc0513989-49f4ddda6d-95653214Purchase Timed Health on Netcapital Series A1 $1 price per share Pre-Money Valuation $11 M Post-Money up to $12 M
- Apr 15, 2021
- Apr 7, 2021Brinkwire on Timed Health...
Brinkwire on Timed Health Corporation
https://en.brinkwire.com/technology/ceo-james-applebach-announces-new-milestone-patented-tech-from-cued-com-joins-timed-health-platform/Press Release Initial Timed Health Offering on Netcapital $1 price per share Pre-Money Valuation $11 M Post-Money up to $12 M
- Apr 6, 2021Timed Health Corporation Press Release Initial...
Timed Health Corporation Press Release Initial Regulatory CF Series A1 Common Stock Offering on Netcapital
https://www.prnewswire.com/news-releases/telehealth-meets-predictive-data-science-timed-health-introduces-a-powerful-patented-platform-to-forecast-healthcare-and-medications-multiplying-physician-and-patient-efficiency-and-erasing-costly-delays-to-improve-health-and-eco-301243370.htmlPress Release Initial Timed Health Offering on Netcapital $1 price per share Pre-Money Valuation $11 M Post-Money up to $12 M
- Apr 6, 2021TECH TIMES published press release Milestone...
TECH TIMES published press release Milestone for Timed Health: acquires patented e-prescriber technology transfer from Cued.com.
https://www.techtimes.com/articles/258708/20210403/ceo-james-applebach-announces-new-milestone-patented-tech-from-cued-com-joins-timed-health-platform.htmPurchase Timed Health on Netcapital Series A1 $1 price per share Pre-Money Valuation $11 M Post-Money up to $12 M
- Apr 6, 2021150 Million Potential Audience Timed Health and...
150 Million Potential Audience Timed Health and NetCapital on YAHOO Finance, Market watch and others.
https://documentcloud.adobe.com/link/track?uri=urn:aaid:scds:US:271c0bcd-2942-4005-8e67-d3ad5875a0e7$1 price per share Pre-Money Valuation $11 M Post-Money up to $12 M
- Apr 2, 2021
- Mar 10, 2021
- Mar 4, 2021Primary offering of $1shares at
- Mar 4, 2021
Ask a Question
Proofread your comment before submitting: once it's posted, you can’t edit or delete it. For the fastest help with the web site, email firstname.lastname@example.org instead of commenting.
Looking to raise capital?
We can help turn your friends, family and customers into investors.
Interested in more investment opportunities?
Browse all offerings currently available.